Research Article

Staphylococcus saprophyticus Recovered from Humans, Food, and Recreational Waters in Rio de Janeiro, Brazil

Table 3

Antimicrobial susceptibility and resistance determinants in 98 Staphylococcus saprophyticus isolates.

Antimicrobial agentDisk diffusion halo (mm)/interpretationMIC (μg/mL)/interpretationResistance determinant
GeneNumber (%) of isolates

Sulfamethoxazole-trimethoprim6–12/R4–64/RdfrG15 (15.3)
6/R32/RdfrA1 (1)
11/I8/RdfrG1 (1)
18–35/S0.125–4/SdfrG10 (10.2)
29–37/S0.125–2/SNone71 (72.4)

 Erythromycin6/R4–≥64/Rerm(C)7 (7.1)
6/R32–>64/Rerm(C), msr(B)2 (2)
6/R>64/Rerm(C), mph(C)2 (2)
6/R≥64/Rmsr(A), msr(B)1 (1)
6/R≥64/Rerm(C), msr(A), msr(B)9 (9.1)
6–10/R32–≥64/Rerm(C), msr(A), msr(B), mph(C)10 (10.2)
19/I0.125/Serm(C)1 (1)
22–33/S0.125–1/Serm(C)44 (44.8)
30/S1/Smsr(A)1 (1)
28–32/S0.25–1/Serm(C), msr(A)7 (7.1)
28–34/S1/Serm(C), msr(B)3 (3)
27–30/S1/Serm(C), mph(C)3 (3)
28–30/S1/Serm(C), msr(A), msr(B)1 (1)
26–32/S0.125–1/SNone7 (7.1)

 Clindamycin30–33/IRa0.125–2/Serm(C)6 (6.1)
34/IRa0.25/Serm(C), msr(B)1 (1)
28–30/IRa0.25/Serm(C), msr(A), msr(B)2 (2)
28–32/IRa0.25/Serm(C), msr(A), msr(B), mph(C)4 (4)
25/S0.25/Slin(A), erm(C), msr(A), msr(B), mph(C)1 (1)
25/S0.25/Slin(A), erm(C)1 (1)
25–35/S0.125–0.25/SNone83 (84.6)

 Oxacillin6–9/R32–>64/RmecA3 (3)
12/R1/RmecA1 (1)
20–22/R0.5–1/RNone5 (5.1)
23–35/S0.5–2/RNone84 (85.7)
29–44/S0.125–0.25/SNone5 (5.1)

 Penicillin6/R8–16/RmecAb3 (3)
15/R2/RNone1 (1)
26–28/R0.25–1/RNone2 (2)
22/R0.125/SmecAb1 (1)
17–27/R0.125/SNone9 (9.1)
30–45/S≤0.125/SNone82 (83.6)

 Gentamicin14/I8/INone1 (1)
15/S8/INone1 (1)
15–37/S0.125/SNone96 (97.9)

 Norfloxacin15/I0.125/SNone1 (1)
17–33/S0.125/SNone97 (98.9)

The 98 isolates in this table were selected from the 140 obtained to include only one isolate per patient. : macrolide-lincosamide-streptogramin B; R: resistant; I: intermediate resistance; S: susceptible; IR: inducible resistance; MIC: minimum inhibitory concentration. inducible resistance detected in -test. isolates resistant to oxacillin.